Back to Search
Start Over
Ocular neuromyotonia: a review of diagnosis and treatment.
- Source :
-
Current opinion in ophthalmology [Curr Opin Ophthalmol] 2022 Nov 01; Vol. 33 (6), pp. 465-470. Date of Electronic Publication: 2022 Aug 17. - Publication Year :
- 2022
-
Abstract
- Purpose of Review: The current review will cover the clinical presentation, causes, epidemiology, differential diagnoses, workup, and treatment of ocular neuromyotonia (ONM) in detail.<br />Recent Findings: While ONM largely remains a unilateral eye movement disease affecting adults with a history of sellar radiation, recent case reports highlight an expansion of this presentation to include bilateral, pediatric, and congenital cases.<br />Summary: ONM is a rare but recognizable ocular motility disorder involving sustained contraction of the extraocular muscle, commonly resulting in intermittent diplopia. Diagnosis of ONM relies upon a thorough history and clinical exam, with particular attention to history of radiotherapy and eccentric gaze testing. Treatment with carbamazepine remains first-line therapy, although other membrane stabilizing agents and surgical interventions can be effective.<br /> (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1531-7021
- Volume :
- 33
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Current opinion in ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 35980029
- Full Text :
- https://doi.org/10.1097/ICU.0000000000000894